Thesis icon

Thesis

Graft-versus-leukaemia antigen discovery utilising the bone marrow T cell repertoire in patients with acute myeloid leukaemia

Abstract:
Acute myeloid leukaemia (AML) is a highly aggressive haematological malignancy for which allogeneic stem cell transplantation (alloSCT) remains the most effective curative therapy. Durable disease control relies on the graft-versus-leukaemia (GvL) effect, where donor-derived T cells eradicate residual leukaemia. Despite over 60 years of clinical use, the identity and dynamics of GvL-specific T cells remain poorly defined, with limited investigation into the early post-alloSCT bone marrow, at a time when relapse risk is greatest.

Using a high-risk, GvL-enriched patient cohort, novel methodological platforms were developed to overcome the limited viability and proliferative capacity of early post-alloSCT bone marrow, enabling the detection and characterisation of rare antigen-specific T cells. Across complementary approaches, multiple GvL clonotypes recognising minor histocompatibility antigens were detected at frequencies as low as 0.01% and shown to persist for years across marrow and blood compartments. Importantly, four clonotypes were identified directly ex vivo, providing unambiguous evidence for their in vivo presence. Phenotypic profiling showed that GSTZ1-specific T cells adopted a Th1-polarised central memory state consistent with long-term surveillance, while functional testing validated a METTL22-specific CD4+ clonotype as an HLA-DR-restricted response that was selective for a patient-derived variant.

These findings establish that GvL immunity can be detected in the marrow within the first post-alloSCT year, persists long-term despite extreme rarity and includes CD4+ T cell subsets with durable effector potential. By expanding the catalogue of validated GvL responses and providing a framework for their detection in the bone marrow, this work advances the understanding of the cellular basis of GvL to inform future developments within the field of transplant immunology.

Actions

Access Document

Files:

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Radcliffe Department of Medicine
Oxford college:
Green Templeton College
Role:
Author

Contributors

Institution:
University of Oxford
Division:
MSD
Department:
Radcliffe Department of Medicine
Role:
Supervisor
ORCID:
0000-0003-3931-0914
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Role:
Supervisor
ORCID:
0000-0002-3877-9780


More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MR/W015846/1
Programme:
Clinical Research Training Fellowship


DOI:
Type of award:
DPhil
Level of award:
Doctoral
Awarding institution:
University of Oxford


Language:
English
Keywords:
Subjects:
Pubs id:
2350267
Local pid:
pubs:2350267
Deposit date:
2025-11-09
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP